SCHEMBL4428644

SCHEMBL4428644

[CH2]Cc1cccc(C)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.38
ACHE P22303 2/20 0.37
KIF11 P52732 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2A6 P11509 1/20 0.35
ALDH1A1 P00352 2/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
TSHR P16473 1/20 0.33
SCN8A Q9UQD0 1/20 0.33
CYP2A13 Q16696 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
PHF8 Q9UPP1 1/20 0.31
PKM P14618 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8441509 0.83 TAAR1 (0.38) MPOACHEKIF11TAAR1CYP1A2
SCHEMBL1145818 0.82 MPO (0.38) MPOACHEKIF11TAAR1CYP1A2
SCHEMBL16954971 0.79 TAAR1 (0.35) MPOACHEKIF11TAAR1CYP1A2
SCHEMBL170934 0.79 GABRA1 (0.46) MPOACHETAAR1CYP1A2CYP2A6
SCHEMBL6405866 0.79 TAAR1 (0.46) MPOACHEKIF11TAAR1CYP1A2
SCHEMBL153087 0.79 P2RX7 (0.35)
SCHEMBL13180051 0.79 MPO (0.39) MPOACHEKIF11TAAR1CYP1A2
SCHEMBL177422 0.77 MPO (0.38) MPOACHEKIF11TAAR1CYP1A2
SCHEMBL1145716 0.77 PDCD1 (0.44) MPOACHETAAR1CYP1A2CYP2A6
SCHEMBL8343195 0.77 MPO (0.38) MPOACHEKIF11TAAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
US-20090082394-A1 Tetrahydroisoquinoline Derivatives to Enhance Memory Function ACTELION PHARMACEUTICALS, LTD. (CH) 2009-03-26 US disclosed
EP-1998774-A1 TETRAHYDROISOQUINOLINE DERIVATIVES TO ENHANCE MEMORY FUNCTION Actelion Pharmaceuticals Ltd. (CH) 2008-12-10 EP disclosed
WO-2007105177-A1 TETRAHYDROISOQUINOLINE DERIVATIVES TO ENHANCE MEMORY FUNCTION ACTELION PHARMACEUTICALS LTD (CH) 2007-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090082394-A1 Tetrahydroisoquinoline Derivatives to Enhance Memory Function GRIN2A, BDNF, GRIN2C MPO 2784/4885ACHE 98/4885KIF11 3201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.